Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion type Assertion NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_head.
- NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_provenance.
- NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion evidence source_evidence_literature NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_provenance.
- NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion SIO_000772 10071127 NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_provenance.
- NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion wasDerivedFrom befree-20150227 NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_provenance.
- NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion wasGeneratedBy ECO_0000203 NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_provenance.